1. Home
  2. BKV vs TMDX Comparison

BKV vs TMDX Comparison

Compare BKV & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BKV Corporation

BKV

BKV Corporation

HOLD

Current Price

$22.95

Market Cap

2.9B

Sector

Energy

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$87.29

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKV
TMDX
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
BKV
TMDX
Price
$22.95
$87.29
Analyst Decision
Strong Buy
Buy
Analyst Count
9
9
Target Price
$34.22
$148.22
AVG Volume (30 Days)
2.0M
625.0K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
199.00
382.18
EPS
1.11
0.61
Revenue
$893,781,000.00
$605,494,000.00
Revenue This Year
$69.39
$24.25
Revenue Next Year
$9.45
$18.75
P/E Ratio
$20.66
$141.47
Revenue Growth
47.85
37.13
52 Week Low
$20.08
$60.11
52 Week High
$32.81
$156.00

Technical Indicators

Market Signals
Indicator
BKV
TMDX
Relative Strength Index (RSI) 39.86 54.02
Support Level N/A $80.29
Resistance Level $27.55 $95.18
Average True Range (ATR) 1.04 4.21
MACD -0.24 -0.29
Stochastic Oscillator 13.62 80.64

Price Performance

Historical Comparison
BKV
TMDX

About BKV BKV Corporation

BKV Corp is a growth-driven energy company focused on the development of natural gas-producing assets, the ownership and operation of natural gas-fired power generation assets, and selective accretive acquisitions. The company's core businesses are the production of natural gas and the generation of natural gas-fired power from its owned and operated assets, supported by a closed-loop plan, enabled by its upstream, midstream, power, and CCUS businesses.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: